CDSCO clears recombinant live attenuated dengue vaccine for ages 4 to 60 years

The Hindu National

‘The approval has been granted after a comprehensive scientific evaluation of the vaccine’s quality, safety and efficacy,’ said the Union Health Ministry ...

전문 보기

이 뉴스, 어떠셨어요?

탭 한 번으로 반응 · 로그인 불필요

관련 뉴스

3건 · 3개 매체

진보 성향 50%중도 성향 50%

1개 매체1개 매체

India approves its first dengue vaccine Qdenga: How it works, who is eligible, and why it isn't a silver bullet

Hindustan Times

진보 성향

India approves first dengue vaccine

Medical Xpress

기타

India approves first dengue vaccine

Free Malaysia Today

중도 성향

관련 뉴스 제보는 로그인 후 가능합니다.

'politics' 카테고리 뉴스

The Hindu의 다른 기사

ADGP M.R. Ajith Kumar submits explanation in YC workers assault case

The Hindu National

Kannur University Syndicate orders probe into K-Reap software issues

The Hindu National

VIT partners with venture capital firms to invest in student startups

The Hindu National

CDSCO clears recombinant live attenuated dengue vaccine for ages 4 to 60 years

이 뉴스, 어떠셨어요?

관련 뉴스

India approves its first dengue vaccine Qdenga: How it works, who is eligible, and why it isn't a silver bullet

India approves first dengue vaccine

India approves first dengue vaccine

'politics' 카테고리 뉴스

Chinese helicopter crosses median line

Food safety law changes to boost oversight, fines

COVID-19 cases surge to epidemic levels: CDC

The Hindu의 다른 기사

ADGP M.R. Ajith Kumar submits explanation in YC workers assault case

Kannur University Syndicate orders probe into K-Reap software issues

VIT partners with venture capital firms to invest in student startups